Stroke care company Imperative Care Inc revealed on Friday the appointment of Daniel Davis as its chief operating officer.
In the senior position in the company, Davis is responsible for the launch and growth of the breakthrough technologies to treat ischemic stroke patients in the US.
Most recently, Davis has served as chief commercial officer and president of North America, Penumbra, where he launched the first FDA-cleared aspiration system for neurovascular mechanical thrombectomy.
The company said Davis brings 19 years of experience in sales, marketing, and business development with both early stage and Fortune 500 medical device, technology and consumer product companies, focused on bringing neurovascular innovations to market.
United Sewing Automation passes test results of NC-manufactured PPE surgical masks
Parnell Pharmaceuticals develops antiviral nasal spray
Quadrant Biosciences wins FDA's EUA for new saliva swab for Covid-19 testing
NeuroRx files for FDA's EUA for RLF-100 in the treatment of patients with critical COVID-19
The FDA approves first POC antibody test for COVID-19 using fingerstick blood samples